CD24 and neoplasm: By targeting 3′UTR of CD24 (CRC CSCs marker), miR-1185-1 negatively regulates CSC features and carcinogenesis, which was evidenced by reduced CSC frequency, colony formation, and migration ability in vitro and decreased tumor size and weight in xenograft model.